A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects
Clinical trial NCT01668537 · COMPLETED
Trial details
- NCT number
- NCT01668537
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-01-01
- Enrollment
- 651
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.